Several studies have consistently reported that the incidence of the del(20q) karyotype, which predicts a good prognosis, is higher in MDS patients with U2AF1 mutations than in patients without U2AF1 mutations [24,27,30,32,38,39,50,51]. The gene discussed is U2AF1; the disease is myelodysplastic syndrome.